These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33804198)

  • 1. Iron Availability in Tissue Microenvironment: The Key Role of Ferroportin.
    Gammella E; Correnti M; Cairo G; Recalcati S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cellular iron deficiency in controlling iron export.
    Link C; Knopf JD; Marques O; Lemberg MK; Muckenthaler MU
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129829. PubMed ID: 33340587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepcidin and ferroportin in full term placenta of pregnant cows.
    Roperto S; Russo V; Urraro C; Cutarelli A; Perillo A; De Falco F; Roperto F
    Theriogenology; 2017 Nov; 103():90-97. PubMed ID: 28780484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PKCα alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin.
    Banerjee S; Lu S; Jain A; Wang I; Tao H; Srinivasan S; Nemeth E; He P
    Blood; 2024 Sep; 144(13):1433-1444. PubMed ID: 38861671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
    Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
    Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.
    De Domenico I; Lo E; Yang B; Korolnek T; Hamza I; Ward DM; Kaplan J
    Cell Metab; 2011 Nov; 14(5):635-46. PubMed ID: 22019085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
    Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
    Elife; 2016 Nov; 5():. PubMed ID: 27897970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
    Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
    Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The iron-regulatory hormone hepcidin: a possible therapeutic target?
    Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C
    Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice with hepcidin-resistant ferroportin accumulate iron in the retina.
    Theurl M; Song D; Clark E; Sterling J; Grieco S; Altamura S; Galy B; Hentze M; Muckenthaler MU; Dunaief JL
    FASEB J; 2016 Feb; 30(2):813-23. PubMed ID: 26506980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ironing out Ferroportin.
    Drakesmith H; Nemeth E; Ganz T
    Cell Metab; 2015 Nov; 22(5):777-87. PubMed ID: 26437604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
    Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M
    Bone; 2020 Aug; 137():115400. PubMed ID: 32380257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing generates a novel ferroportin isoform with a shorter C-terminal and an intact iron- and hepcidin-binding property.
    Juneja P; Rashid N; Abul Qais F; Tanwar S; Sultan I; Ahmad F; Rehman SU
    IUBMB Life; 2024 Aug; 76(8):523-533. PubMed ID: 38348962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice overexpressing hepcidin suggest ferroportin does not play a major role in Mn homeostasis.
    Jin L; Frazer DM; Lu Y; Wilkins SJ; Ayton S; Bush A; Anderson GJ
    Metallomics; 2019 May; 11(5):959-967. PubMed ID: 30888356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the functional properties of human and mouse ferroportin.
    Azucenas CR; Ruwe TA; Bonamer JP; Qiao B; Ganz T; Jormakka M; Nemeth E; Mackenzie B
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1110-C1118. PubMed ID: 36939203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron and hepcidin: a story of recycling and balance.
    Camaschella C
    Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients.
    Ambachew S; Biadgo B
    Acta Haematol; 2017; 138(4):183-193. PubMed ID: 29136618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.